Jennifer Young, the founder of the eponymously-named skin care brand created for cancer patients, has gained the backing of a UK venture capital business.
The company has received significant investment from the Midlands Engine Investment Fund (MEIF) West Midlands Equity Fund, managed by Birmingham-based venture capital firm Midven.
Founded in 2013, Jennifer Young sells a range of skin and make-up products for people undergoing different types of treatment including chemotherapy or radiotherapy, as well as those in remission.
Young said: “As a business, we aim to support as many people receiving cancer treatment as possible.
“The funding we’ve received from the MEIF will allow us to continue to
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Cosmetics Business.
Subscribe now Already a subscriber? Sign in here.
